ClinicalTrials.gov
public full text
Public Domain
A Study of LY3841136 in Healthy and Overweight Participants
The main purpose of this study is to evaluate the safety and tolerability of LY3841136 in healthy and overweight participants. Blood tests will be performed to check how much LY3841136 gets into the bloodstream and how long it takes the body to eliminate it. This is a 2-part study and may last up to 14 and 28 weeks for each participant and may include 7 and 19 visits in parts A and B, respectively.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of LY3832479 (LY-CoV016) in Healthy Participants#1152266
- A Study of LY3819253 (LY-CoV555) in Healthy Participants#845480
- A Study of LY3437943 in Chinese Participants With Obesity Or Overweight#1112131
- A Study of LY3325656 in Healthy Participants and Participants With Type 2 Diabetes#862442
- A Study of Multiple Doses of LY3305677 in Healthy Participants#993158
Record · ID 876778
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive